Patents Examined by Jessica H. Roack
  • Inhibition of LERK-2-mediated cell adhesion
    Patent number: 6514497
    Abstract: Methods of modulating LERK-2-mediated cell adhesion, as well as methods of modulating angiogenesis and inflammation are described. Also described are agents such as antibodies which can modulate LERK-2-mediated cell adhesion, as well as methods of treating angiogenic diseases and inflammatory diseases.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: February 4, 2003
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Michael J. Briskin, Lily Zou